Akita University Hospital
About Akita University Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
19
Celgene
3
Bayer
2
Ferring Pharmaceuticals
2
Janssen Pharmaceutical K.K.
2
Amgen
1
Ariad Pharmaceuticals
1
Astex Pharmaceuticals, Inc.
1
BeiGene
1
Chugai Pharmaceutical
1
Daiichi Sankyo, Inc.
1
Clinical Trials at Akita University Hospital
During the past decade, Akita University Hospital conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 18 clinical trials were completed, i.e. on
average, 58.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 13 clinical trials were completed. i.e. 118.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
2006-03-01
2010-10-01
Completed
628
S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer
2006-04-01
Unknown status
500
Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)
2007-12-12
2012-10-30
Completed
64
Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
2008-02-05
2015-05-27
Completed
502
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
2008-09-03
2016-02-25
Completed
723
Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive Leukemias
2007-12-01
2015-06-01
Completed
63
Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
2009-08-01
2016-02-01
Completed
213
Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis
2010-01-01
2010-09-01
Completed
89
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Akita University Hospital" #1 sponsor was "Pfizer" with 19 trials, followed by "Celgene" with 3 trials
sponsored, "Bayer" with 2 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored and "Janssen Pharmaceutical K.K."
with 2 trials sponsored. Other sponsors include 16 different institutions and
companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Akita University Hospital"
#1 collaborator was "UCB Pharma" with 2 trials as a collaborator, "Japan Breast Cancer Research Group (JBCRG)" with 1 trials as a collaborator, "Japan Lung Cancer Society" with 1 trials as a collaborator, "Korean Cancer Study Group" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Akita University Hospital
According to Clinical.Site data, the most researched conditions in "Akita University Hospital" are
"Acute Myeloid Leukemia" (3 trials), "Carcinoma, Renal Cell" (3 trials), "Chronic Myeloid Leukemia" (2 trials), "Eosinophilic Esophagitis" (2 trials) and "Lymphoma, Large B-Cell, Diffuse" (2 trials). Many other conditions were trialed in "Akita University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Akita University Hospital
Most popular intervention types in "Akita University Hospital" are "Drug" (43 trials), "Other" (4 trials), "Biological" (3 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Apalutamide" (2 trials), "Axitinib (AG-013736)" (2 trials), "Bosutinib" (2 trials) and "CC-93538" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Akita University Hospital
The vast majority of trials in "Akita University Hospital" are
45 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Akita University Hospital
Currently, there are NaN active trials in "Akita University Hospital".
undefined are not yet recruiting,
8 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 28 completed trials in Akita University Hospital,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Akita University Hospital, 4 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 30 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".